Surgical selection in cervical cancer, how can we move forward?
Elisa Piovano, Jacopo Di Muzio, Santino Arienzale, Luca Fuso et autres
it, fr (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
Dionyssios Katsaros
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
442Publications signalées
25781Citations signalées
4Affiliations récentes
Les institutions déclarées
Les domaines associés
Ovarian cancer diagnosis and treatmentMicroRNA in disease regulationCancer-related molecular mechanisms researchEndometrial and Cervical Cancer TreatmentsCircular RNAs in diseases
Les publications récentes
Integrating clinical and molecular biomarkers to predict chemotherapy outcomes in high-grade serous ovarian carcinoma
Stefano Fucina, Fulvio Borella, Pietro Denti, Saverio Danese et autres
it, by, ua (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
ENGOT-ov62 - reducing chemotherapy duration in high-grade advanced ovarian cancer: A comparison of 3 vs. 6 cycles of platinum-based chemotherapy followed by niraparib maintenance in HRD-positive patients
Jalid Sehouli, Eva Roser, Robert Armbrust, Dario Zocholl et autres
de, at, cz, be, es, it (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
Regional Audit and Feedback Intervention to Improve Quality of Care in Ovarian Cancer Treatment: The Easy-Net Experience
Elisa Piovano, Annamaria Ferrero, Giovannino Ciccone, Marco Camanni et autres
it (code pays fourni par la source)
0 citations
JCO Oncology Practice
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 Trial
Cathalijne Post, Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et autres
nl, fr, au (code pays fourni par la source)
1 citation
Obstetrical & Gynecological Survey
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trial
Cathalijne Post, Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et autres
nl, gb, au, it, ca, fr (code pays fourni par la source)
37 citations
The Lancet Oncology
10O Efficacy according to PD-L1 status in the BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) randomised phase III trial of first-line atezolizumab (atezo), chemotherapy (CT) and bevacizumab (bev) for metastatic, persistent or recurrent cervical cancer (R/M CC)
Ugo De Giorgi, Luigi Mansi, J. Martinez-Garcia, Guillermo Villacampa et autres
it, fr, es, us, jp, no, de, se (code pays fourni par la source)
4 citations
ESMO Open
Mitochondrial tRNA fragment, mt-tRF-Tyr-GTA-001 (tRF-21-X3OJI8EWB), in breast cancer and its potential clinical implications
Junlong Wang, Dionyssios Katsaros, Zhanwei Wang, Li Ma et autres
us, it (code pays fourni par la source)
2 citations
Breast Cancer Research and Treatment
Real-Life Feasibility Of Multiple-Drugs Regimens Including Pembrolizumab In The Treatment Of Persistent, Recurrent Or Metastatic Cervical Cancer
Elisa Piovano, Elena Casetta, Fulvio Borella, Maria Pia Chiparo et autres
it (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
Systemic Immune Inflammation Index: An Actionable Tool For Early Detection Of The Relapse During Maintenance With PARPi In Ovarian Cancer Patients
Elisa Piovano, Maria Pia Chiparo, Fulvio Borella, Elena Casetta et autres
it (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
The “N-PLUS/NOGGO-Ov53/ENGOT-Ov62-STUDY” To De-Escalate Chemotherapy In Ovarian Cancer: Comparing 3 Vs. 6 Cycles Of Platinum-Based Chemotherapy After Complete Tumor Resection Followed By Niraparib Maintenance In HRD+ High-Grade Advanced OC
Elena Ioana Braicu, Klaus Pietzner, Dario Zocholl, Katja Gnausch et autres
de, at, be, cz, es, it (code pays fourni par la source)
0 citations
International Journal of Gynecological Cancer
Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning
Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf et autres
nl, ch, dk, gb, au, ca, fr, it (code pays fourni par la source)
4 citations
Nature Medicine
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.